Dec 10, 2019
OTTAWA – The Government of Canada is committed to informing Canadians about the risks of health products that contain opioids. As a result, Health Canada is advising Canadians that people under 18 years of age should not use non-prescription pain relief products containing codeine. Non-prescription codeine-containing pain relief products were previously not recommended for children and youth under 12 years of age.
July 28, 2020 For immediate release
Health Canada is providing an update on the status of ranitidine drugs in Canada, including enhanced safety measures the Department is putting in place to detect an impurity called N-nitrosodimethylamine (NDMA).
Ferring Inc. is recalling three lots of DDAVP Spray (desmopressin acetate nasal solution, 10 micrograms/spray) because the product may contain a higher than labelled dose of the active ingredient (desmopressin) and could pose an overdose risk.